This site is optimised for modern browsers. For the best experience, please use Google Chrome, Mozilla Firefox, or Microsoft Edge.

Drug reduces fatigue in people with long COVID, study finds

Researchers from the University of Oxford have reported that new drug AXA1125 is an effective treatment for tiredness in people with long COVID.

The national study found that participants who took the drug showed a significant improvement in fatigue, compared to those who were given a placebo, or dummy drug.

A total of 41 patients were recruited in Oxford.

Read more information on the University of Oxford’s website.